Ad is loading...
REVB
Price
$0.80
Change
-$0.04 (-4.76%)
Updated
Nov 15 closing price
TCRT
Price
$2.09
Change
-$0.25 (-10.68%)
Updated
Nov 15 closing price
Ad is loading...

REVB vs TCRT

Header iconREVB vs TCRT Comparison
Open Charts REVB vs TCRTBanner chart's image
Revelation Biosciences
Price$0.80
Change-$0.04 (-4.76%)
Volume$240.72K
CapitalizationN/A
Alaunos Therapeutics
Price$2.09
Change-$0.25 (-10.68%)
Volume$22.59K
CapitalizationN/A
REVB vs TCRT Comparison Chart
Loading...
REVB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TCRT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
REVB vs. TCRT commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REVB is a Sell and TCRT is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (REVB: $0.80 vs. TCRT: $2.09)
Brand notoriety: REVB and TCRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REVB: 37% vs. TCRT: 109%
Market capitalization -- REVB: $3.45M vs. TCRT: $3.35M
REVB [@Biotechnology] is valued at $3.45M. TCRT’s [@Biotechnology] market capitalization is $3.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REVB’s FA Score shows that 2 FA rating(s) are green whileTCRT’s FA Score has 1 green FA rating(s).

  • REVB’s FA Score: 2 green, 3 red.
  • TCRT’s FA Score: 1 green, 4 red.
According to our system of comparison, REVB is a better buy in the long-term than TCRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REVB’s TA Score shows that 4 TA indicator(s) are bullish while TCRT’s TA Score has 4 bullish TA indicator(s).

  • REVB’s TA Score: 4 bullish, 6 bearish.
  • TCRT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TCRT is a better buy in the short-term than REVB.

Price Growth

REVB (@Biotechnology) experienced а -2.07% price change this week, while TCRT (@Biotechnology) price change was +5.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

REVB is expected to report earnings on Mar 01, 2023.

TCRT is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REVB($3.45M) and TCRT($3.35M) have the same market capitalization . TCRT YTD gains are higher at: -80.292 vs. REVB (-94.654). REVB has higher annual earnings (EBITDA): -9.5M vs. TCRT (-18.21M). REVB has more cash in the bank: 12.1M vs. TCRT (2.46M). REVB (0) and TCRT (0) have identical debt. TCRT has higher revenues than REVB: TCRT (7K) vs REVB (0).
REVBTCRTREVB / TCRT
Capitalization3.45M3.35M103%
EBITDA-9.5M-18.21M52%
Gain YTD-94.654-80.292118%
P/E RatioN/AN/A-
Revenue07K-
Total Cash12.1M2.46M491%
Total Debt00-
FUNDAMENTALS RATINGS
TCRT: Fundamental Ratings
TCRT
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
REVBTCRT
RSI
ODDS (%)
Bearish Trend 3 days ago
70%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
59%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
70%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
39%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
REVB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TCRT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PIII0.230.02
+9.12%
P3 Health Partners
UFCS25.420.39
+1.56%
United Fire Group
LAUR18.510.21
+1.15%
Laureate Education
BXP78.53-0.94
-1.18%
BXP Inc.
INM4.28-0.80
-15.73%
InMed Pharmaceuticals Inc

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
-4.02%
GNPX - REVB
48%
Loosely correlated
-2.44%
TCRT - REVB
46%
Loosely correlated
-10.59%
TOVX - REVB
31%
Poorly correlated
+0.74%
TSHA - REVB
31%
Poorly correlated
-9.25%
CVKD - REVB
27%
Poorly correlated
-5.49%
More

TCRT and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRT has been loosely correlated with NRBO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRT jumps, then NRBO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRT
1D Price
Change %
TCRT100%
-10.59%
NRBO - TCRT
50%
Loosely correlated
-7.11%
SNTI - TCRT
47%
Loosely correlated
-7.73%
REVB - TCRT
46%
Loosely correlated
-4.02%
BRTX - TCRT
33%
Loosely correlated
-3.97%
ALNY - TCRT
30%
Poorly correlated
-8.67%
More